1. Home
  2. RLGT vs TECX Comparison

RLGT vs TECX Comparison

Compare RLGT & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RLGT

Radiant Logistics Inc.

N/A

Current Price

$8.86

Market Cap

408.7M

ML Signal

N/A

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$20.47

Market Cap

371.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
RLGT
TECX
Founded
2001
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
408.7M
371.0M
IPO Year
2006
2018

Fundamental Metrics

Financial Performance
Metric
RLGT
TECX
Price
$8.86
$20.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
10
Target Price
$11.00
★ $71.00
AVG Volume (30 Days)
136.7K
★ 159.3K
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
11.43
★ 40.70
EPS
★ 0.39
N/A
Revenue
★ $934,356,000.00
N/A
Revenue This Year
$4.96
N/A
Revenue Next Year
$4.98
N/A
P/E Ratio
$24.62
★ N/A
Revenue Growth
★ 3.51
N/A
52 Week Low
$5.86
$16.77
52 Week High
$10.20
$39.53

Technical Indicators

Market Signals
Indicator
RLGT
TECX
Relative Strength Index (RSI) 47.05 43.99
Support Level $8.14 $20.52
Resistance Level $9.05 $23.03
Average True Range (ATR) 0.27 1.21
MACD 0.01 0.23
Stochastic Oscillator 36.76 52.88

Price Performance

Historical Comparison
RLGT
TECX

About RLGT Radiant Logistics Inc.

Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services, including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: